drugset / Trial / NCT07342114
A Dose-Escalation Study of RO7875913 in Healthy Participants
RandomizedSequentialQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety, pharmacokinetics, and pharmacodynamics of RO7875913 in healthy participants.
Timeline
- Start
- 2026-03-11
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RO7875913 | Unknown | — | — |
Indications
No indication recorded.